102 related articles for article (PubMed ID: 4563299)
1. Myeloma and leukaemia trials.
Peto R
Proc R Soc Med; 1972 Mar; 65(3):244-5. PubMed ID: 4563299
[No Abstract] [Full Text] [Related]
2. Monitoring myelomatosis.
Hobbs JR
Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
[TBL] [Abstract][Full Text] [Related]
3. Proposed guidelines for protocol studies. I. Introduction. II. Plasma cell myeloma. 3. Chronic lymphocytic leukemia. IV. Chronic granulocytic leukemia.
Cancer Chemother Rep 3; 1973 Jan; 4(1):141-73. PubMed ID: 4574252
[No Abstract] [Full Text] [Related]
4. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
[No Abstract] [Full Text] [Related]
5. Myeloma and related disorders.
Kyle RA; Durie BG; Boccadoro M; Pavlovsky S
Rev Invest Clin; 1994 Apr; Suppl():46-51. PubMed ID: 7886308
[No Abstract] [Full Text] [Related]
6. Urea, albumin, and response rates.
Peto R
Br Med J; 1971 May; 2(5757):324. PubMed ID: 5575239
[No Abstract] [Full Text] [Related]
7. Is the newly proposed prognostic system for multiple myeloma useful?
Montera Garcia JM; Felin J; Artal A; González Barón M; López Pascual J; Fernández Rañada JM
Br J Haematol; 1990 May; 75(1):140-1. PubMed ID: 2375916
[No Abstract] [Full Text] [Related]
8. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
Tichý M; Maisnar V; Palicka V; Friedecký B; Vávrová J; Novotná H; Cermáková Z; Dastych M; Cechák P; Vogtová D; Jarolímková E; Benáková H; Hachová L; Bezdícková D; Kouril F; Zábranská EA; Zenková J; Slabý P; Scudla V; Gregora E; Spicka I; Straub J; Schützova M; Hájek R
Neoplasma; 2006; 53(6):492-4. PubMed ID: 17167717
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials referral resource. Clinical trials with arsenic trioxide.
Murgo AJ; McBee WL; Cheson BD
Oncology (Williston Park); 2000 Feb; 14(2):206, 211, 215-6 passim. PubMed ID: 10736809
[No Abstract] [Full Text] [Related]
10. International staging system for multiple myeloma.
Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma. 2. A report on sixty-seven cases.
Hill RS; Wilson JD
N Z Med J; 1968 Feb; 67(428):194-203. PubMed ID: 5238829
[No Abstract] [Full Text] [Related]
12. [Prognosis of multiple myeloma].
Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
[No Abstract] [Full Text] [Related]
13. Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.
Depil S; Mathiot C; Leleu X; Moreau AS; Faucompré JL; Hennache B; Bauters F; Bataille R; Facon T
Br J Haematol; 2005 Jun; 129(5):706-7. PubMed ID: 15916694
[No Abstract] [Full Text] [Related]
14. Proposed guidelines for protocol studies. II. Plasma cell myeloma. Prepared by a Committee of the Chronic Leukemia--Myeloma Task Force, National Cancer Institute.
Cancer Chemother Rep 3; 1968 Dec; 1(1):17-39. PubMed ID: 4195760
[No Abstract] [Full Text] [Related]
15. Clinical impact of discordance in serum albumin measurements on myeloma international staging system.
Kapoor P; Snozek CL; Colby C; Larson DR; Katzmann JA; Rajkumar SV; Greipp PR
J Clin Oncol; 2008 Aug; 26(24):4051-2. PubMed ID: 18711203
[No Abstract] [Full Text] [Related]
16. A new prognostic system for multiple myeloma based on easily available parameters.
Bladé J; Rozman C; Cervantes F; Reverter JC; Montserrat E
Br J Haematol; 1989 Aug; 72(4):507-11. PubMed ID: 2775656
[TBL] [Abstract][Full Text] [Related]
17. [Multiple myeloma and chronic lymphocytic leukemia].
Labardini-Méndez J; Alexanian R; Barlogie B
Rev Invest Clin; 1997 May; 49 Suppl 1():28-33. PubMed ID: 9380986
[No Abstract] [Full Text] [Related]
18. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
Alexanian R; Migliore PJ
J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
[No Abstract] [Full Text] [Related]
19. [Optimising therapy in patients with haematological malignancies].
Dumontet C
Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
[TBL] [Abstract][Full Text] [Related]
20. [Interleukin-6 reflects the disease severity and prognosis of myeloma].
Pelliniemi TT; Pulkki K
Duodecim; 1996; 112(7):563-5. PubMed ID: 10592621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
